The emerging approach of the medication represents a major breakthrough in the management of the condition. Distinct from existing medications, tirzepatide affects dual pathways – glucagon-like peptide-1 (GLP-1) and https://tirzepatidepeptide883269.blogacep.com/47675786/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment